These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 26035747)

  • 1. Nivolumab (Opdivo) for metastatic melanoma and metastatic NSCLC.
    Med Lett Drugs Ther; 2015 Jun; 57(1470):85-7, 94. PubMed ID: 26035747
    [No Abstract]   [Full Text] [Related]  

  • 2. Addendum: Nivolumab (Opdivo) for metastatic melanoma and metastatic NSCLC.
    Med Lett Drugs Ther; 2015 Jun; 57(1471):94. PubMed ID: 26079767
    [No Abstract]   [Full Text] [Related]  

  • 3. PD-1 Blockers.
    Wolchok JD
    Cell; 2015 Aug; 162(5):937. PubMed ID: 26317459
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential Activity of Nivolumab, Pembrolizumab and MPDL3280A according to the Tumor Expression of Programmed Death-Ligand-1 (PD-L1): Sensitivity Analysis of Trials in Melanoma, Lung and Genitourinary Cancers.
    Carbognin L; Pilotto S; Milella M; Vaccaro V; Brunelli M; Caliò A; Cuppone F; Sperduti I; Giannarelli D; Chilosi M; Bronte V; Scarpa A; Bria E; Tortora G
    PLoS One; 2015; 10(6):e0130142. PubMed ID: 26086854
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nivolumab: a review in advanced squamous non-small cell lung cancer.
    Keating GM
    Drugs; 2015 Nov; 75(16):1925-34. PubMed ID: 26514815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Not Available].
    Moro-Sibilot D; Ferrer L; Levra MG; Toffart AC
    Bull Cancer; 2016 Jun; 103(6 Suppl 1):S12-5. PubMed ID: 27494968
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trastuzumab in the treatment of advanced non-small-cell lung cancer: is there a role?
    Kalemkerian G
    J Clin Oncol; 2005 Feb; 23(6):1325-6; author reply 1326-7. PubMed ID: 15718337
    [No Abstract]   [Full Text] [Related]  

  • 8. Pembrolizumab (Keytruda) for first-line treatment of metastatic NSCLC.
    Med Lett Drugs Ther; 2017 Jan; 59(1513):22-23. PubMed ID: 28118650
    [No Abstract]   [Full Text] [Related]  

  • 9. Psoriasis and psoriatic arthritis induced by nivolumab in a patient with advanced lung cancer.
    Law-Ping-Man S; Martin A; Briens E; Tisseau L; Safa G
    Rheumatology (Oxford); 2016 Nov; 55(11):2087-2089. PubMed ID: 27436004
    [No Abstract]   [Full Text] [Related]  

  • 10. Nivolumab--an effective second-line treatment for NSCLC.
    Romero D
    Nat Rev Clin Oncol; 2015 Dec; 12(12):685. PubMed ID: 26483299
    [No Abstract]   [Full Text] [Related]  

  • 11. Immunotherapy: pembrolizumab-is the writing on the wall for cancer?
    Hutchinson L
    Nat Rev Clin Oncol; 2015 Jul; 12(7):371. PubMed ID: 25963092
    [No Abstract]   [Full Text] [Related]  

  • 12. Immunotherapy drug improves survival of patients with squamous non-small cell lung cancer.
    Printz C
    Cancer; 2015 Oct; 121(20):3562-3. PubMed ID: 26431439
    [No Abstract]   [Full Text] [Related]  

  • 13. [Nivolumab, a new hope in non-small cell lung cancer].
    Flippot R; Fallet V; Besse B; Massard C; Wislez M; Vignot S
    Bull Cancer; 2015 Dec; 102(12):1046-52. PubMed ID: 26585939
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nivolumab (Opdivo°) and metastatic or inoperable lung cancer.
    Prescrire Int; 2017 Apr; 26(181):93-94. PubMed ID: 30730658
    [No Abstract]   [Full Text] [Related]  

  • 15. Toward customized trastuzumab in HER-2/neu-overexpressing non-small-cell lung cancers.
    Rosell R
    J Clin Oncol; 2004 Apr; 22(7):1171-3. PubMed ID: 14981109
    [No Abstract]   [Full Text] [Related]  

  • 16. Nivolumab: a review of its use in patients with malignant melanoma.
    Deeks ED
    Drugs; 2014 Jul; 74(11):1233-9. PubMed ID: 25022950
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Will FLEX allow us flexibility in the therapy of advanced non-small-cell lung cancer? Insights from the 2008 American Society of Clinical Oncology Meeting.
    Langer CJ
    Clin Lung Cancer; 2008 Sep; 9(5):249-51. PubMed ID: 18824445
    [No Abstract]   [Full Text] [Related]  

  • 18. Bevacizumab extends survival for patients with nonsquamous non-small-cell lung cancer.
    Belani CP; Ramalingam S
    Clin Lung Cancer; 2005 Mar; 6(5):267-8. PubMed ID: 15845175
    [No Abstract]   [Full Text] [Related]  

  • 19. Lung cancer: looking ahead in 2004.
    Belani CP; Ramalingam S
    Clin Lung Cancer; 2004 Jan; 5(4):200. PubMed ID: 14967070
    [No Abstract]   [Full Text] [Related]  

  • 20. [Nivolumab for metastatic melanoma-basic knowledge and clinical data].
    Yamazaki N; Maeda Y
    Gan To Kagaku Ryoho; 2015 Apr; 42(4):434-8. PubMed ID: 26020984
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.